{{Drugbox
| Verifiedfields = changed
| Watchedfields = changed
| verifiedrevid = 457619723
<!--Combo data-->
| type = combo
| component1 = 蒿甲醚
| class1 = [[抗疟药|抗疟药]]
| component2 = 苯芴醇
| class2 = [[抗疟药|抗疟药]]
<!--Clinical data-->
| tradename = Coartem、Riamet、Falcynate-LF
| Drugs.com = {{drugs.com|monograph|artemether-and-lumefantrine}}
| MedlinePlus = a609024
| pregnancy_AU = D
| pregnancy_US = C
| pregnancy_category =  
| legal_AU = S4
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C -->
| legal_US = Rx-only
| legal_status =  
| routes_of_administration = Oral
<!--Identifiers-->
| ATC_prefix = P01
| ATC_suffix = BF01
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 21106282
<!--Chemical data-->
}}
<!-- Definition and medical uses -->
'''複方蒿甲醚'''（Artemether/lumefantrine），常見商品名'''Coartem'''，為由[[蒿甲醚|蒿甲醚]]及[[苯芴醇|苯芴醇]]混和而成的副方[[抗瘧藥|抗瘧藥]]<ref name=AHFS2015>{{cite web|title=Artemether and Lumefantrine|url=https://www.drugs.com/monograph/artemether-and-lumefantrine.html|publisher=The American Society of Health-System Pharmacists|accessdate=Dec 2, 2015|deadurl=no|archiveurl=https://web.archive.org/web/20151208162852/http://www.drugs.com/monograph/artemether-and-lumefantrine.html|archivedate=2015-12-08|df=}}</ref>。本品主要用於對抗具有[[氯喹|氯喹]]抗藥性的[[恶性疟原虫|恶性疟原虫]]<ref name=AHFS2015/>，本品通常不會用於預防瘧疾<ref name=AHFS2015/>，為一種口服藥劑<ref name=AHFS2015/>。

<!-- Side effects and mechanism -->
常見副作用包含肌肉痠痛、發燒、食慾不振，已及頭痛<ref name=AHFS2015/>。嚴重副作用則包含[[長QT綜合症|長QT綜合症]]<ref name=AHFS2015/>。[[妊娠|妊娠]]期間用藥的安全性尚未明朗<ref name=AHFS2015/>，輕微肝腎問題者不需調整劑量<ref name=AHFS2015/>。

<!-- History, society, and culture -->
該複方藥劑於1992年開始藥用<ref name=Enr2011>{{cite book|last1=Ravina|first1=Enrique|title=The evolution of drug discovery : from traditional medicines to modern drugs|date=2011|publisher=Wiley-VCH|location=Weinheim|isbn=9783527326693|page=139|edition=1. Aufl.|url=https://books.google.ca/books?id=iDNy0XxGqT8C&pg=PA139|deadurl=no|archiveurl=https://web.archive.org/web/20151208072054/https://books.google.ca/books?id=iDNy0XxGqT8C&pg=PA139|archivedate=2015-12-08|df=}}</ref>，且本品的主成分蒿甲醚及苯芴醇皆由[[中國|中國]]所開發<ref name=Enr2011/><ref>{{cite book|last1=Nightingale|first1=Charles H.|title=Antimicrobial pharmacodynamics in theory and clinical practice|date=2007|publisher=Informa Healthcare|location=New York|isbn=9781420017137|page=380|edition=2nd|url=https://books.google.ca/books?id=sXf42EROuhEC&pg=PA380|deadurl=no|archiveurl=https://web.archive.org/web/20151208050646/https://books.google.ca/books?id=sXf42EROuhEC&pg=PA380|archivedate=2015-12-08|df=}}</ref>。本品列名於[[世界卫生组织基本药物标准清单|世界卫生组织基本药物标准清单]]之中，為基礎公衛體系必備藥物之一<ref name=WHO19th>{{cite web|title=WHO Model List of Essential Medicines (19th List)|url=http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|work=World Health Organization|accessdate=8 December 2016|date=April 2015|deadurl=no|archiveurl=https://web.archive.org/web/20161213052708/http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|archivedate=13 December 2016|df=}}</ref>。2014年，本品在在[[发展中国家|发展中国家]]的每日劑量批發價約介於0.10至1.2美金之間<ref>{{cite web|title=Artemether + Lumefantrine|url=http://mshpriceguide.org/en/single-drug-information/?DMFId=1441&searchYear=2014|website=International Drug Price Indicator Guide|accessdate=4 December 2015|deadurl=yes|archiveurl=https://web.archive.org/web/20180122125102/http://mshpriceguide.org/en/single-drug-information/?DMFId=1441&searchYear=2014|archivedate=2018年1月22日}}</ref>。本品屬於[[通用名药物|通用名药物]]，在美國單次療程的花費約介於100至200美金之間<ref name=Ric2015>{{cite book|last1=Hamilton|first1=Richart|title=Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition|date=2015|publisher=Jones & Bartlett Learning|isbn=9781284057560|page=45}}</ref>。

== 參考文獻 ==
{{Reflist|colwidth=30em}}

{{Antimalarials}}

[[Category:抗疟疾剂|Category:抗疟疾剂]]
[[Category:複方藥|Category:複方藥]]
[[Category:中国发明|Category:中国发明]]
[[Category:世界卫生组织基本药物|Category:世界卫生组织基本药物]]

{{portal bar|药理学|醫學}}